WORXE Worlds Online Inc

MariMed and Benzinga Present Inaugural Bob Fireman Entrepreneur of the Year Award To Ardent Life Founder Shanel Lindsay

MariMed and Benzinga Present Inaugural Bob Fireman Entrepreneur of the Year Award To Ardent Life Founder Shanel Lindsay

Award Honors the Legacy of MariMed’s Late Co-Founder

NORWOOD, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator (“MariMed”) (CSE: MRMD) (OTCQX: MRMD) and media and data technology platform Benzinga unveiled the Bob Fireman Entrepreneur of the Year Award for the first time at a ceremony held September 27th during the 2023 Benzinga Cannabis Capital Conference in Chicago. MariMed CEO and President Jon Levine and Benzinga VP/Events & Head of Cannabis Elliot Lane presented the award to Shanel Lindsay, Founder and President of , for her work that bridges cannabis science and policymaking.

The Bob Fireman Entrepreneur of the Year Award honors the legacy of MariMed’s co-founder and CEO, who passed away in December 2022. Fireman was a pioneer and visionary of the legal cannabis industry. He entered the industry in 2008 with Levine through an investment in a California cannabis business. The award is presented to a cannabis industry executive who embodies Fireman’s entrepreneurial spirit and success, as well as his staunch advocacy for medical cannabis patient’s rights.

Lindsay is an attorney, entrepreneur, and longtime force in the Massachusetts cannabis industry. She invented the NOVA™, a laboratory-grade precision decarboxylator for medical cannabis patients. She went on to create Ardent Life Inc., a company known for innovation in cannabis biotech and medical devices. The multi-million dollar global brand develops CPG products and infusion accessories. Additionally, she is a two-time appointee to the Massachusetts Cannabis Advisory Board, which makes regulation and taxation recommendations to the Cannabis Control Commission.

“Bob always worked hard as a business leader, attorney, and advocate for our industry. He guided MariMed to deliver on our mission to improve people’s lives through cannabis,” said Levine. “Shanel is likewise has set a positive course for Massachusetts cannabis consumers. She is a deserving recipient of this award because she puts her cannabis science expertise to use to improve the lives of others. We know Bob would be pleased and I’m extremely proud to honor his legacy with the establishment of this award.”

“Bob’s passing left a void, but not before laying a roadmap for what integrity and ingenuity should look like in the cannabis industry,” said Lane. “We are thrilled to partner with MariMed to create the Bob Fireman Entrepreneur of the Year Award and equally excited to honor Shanel as its first recipient.”

A serial entrepreneur and a practicing attorney for over 30 years, Fireman’s legal acumen and entrepreneurial experience in diverse industries served as tremendous assets in navigating MariMed through the complex, emerging cannabis industry. Together, he and Levine built MariMed to become one of the most financially sound companies in cannabis. As an advocate for medical cannabis patient rights, he put a heavy emphasize on education and worked tirelessly to help gain access to legal cannabis for everyone who needs it.

Under Fireman’s leadership as Chairman of the Board of Directors, CEO and President, the MariMed team applied for—and was awarded—cannabis business licenses in multiple states and developed many state-of-the-art cultivation, production and retail facilities.

About MariMed:

MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit .

Company Contact:

Howard Schacter

Chief Communications Officer

Email:

Phone: (781) 277-0007

Investor Relations Contact:

Steve West

Vice President, Investor Relations

Email:

Phone: (781) 277-0007



EN
28/09/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Worlds Online Inc

 PRESS RELEASE

MariMed Extends Series B Preferred Stock Obligation Through 2031, Stre...

MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today that it has entered into a Restructuring and Exchange Agreement (the “Agreement”) with the holders (the “Holders”) of its $14.725 million Series B Convertible Preferred Stock (the “Series B Obligation”). The restructuring extends the maturity of the Company’s obligations on favorable market term...

 PRESS RELEASE

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date NORWOOD, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- . (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its fourth quarter and full year 2025 financial results on March 11, 2026 after the markets close. Management will host a conference call on March 12, 2026 at 8:00 a.m. EDT to discuss financial results. A webcast will be available and can be accessed via MariMed’s Investor Relations website at . A playback of the call will...

 PRESS RELEASE

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s S...

MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing Fun NORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and d...

 PRESS RELEASE

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand ...

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental cultivation or retail infrast...

 PRESS RELEASE

MariMed Statement on Historic Rescheduling of Cannabis

MariMed Statement on Historic Rescheduling of Cannabis NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following statement from CEO Jon Levine today. “We commend President Trump and the Trump Administration for reclassifying cannabis as a Schedule III drug. This is the single greatest cannabis reform in US history and will have far-reaching benefits for years to come. Most important, the reclassification means the Federal government officially a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch